Anti-inflammatory Elafin in human fetal membranes

Cecilia Stalberg, Nathalia Noda, Jossimara Polettini, Bo Jacobsson, Ramkumar Menon

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Elafin is a low molecular weight protein with antileukoproteinase, anti-inflammatory, antibacterial and immunomodulating properties. The profile of Elafin in fetal membranes is not well characterized. This study determined the changes in Elafin expression and concentration in human fetal membrane from patients with preterm prelabor rupture of membranes (PPROM) and in vitro in response to intra-amniotic polymicrobial pathogens. Elafin messenger RNA (mRNA) expressions were studied in fetal membranes from PPROM, normal term as well as in normal term not in labor membranes in an organ explant system treated (24 h) with lipopolysaccharide (LPS), using quantitative reverse transcription-polymerase chain reaction (RT-PCR). Enzyme-linked immunosorbent assay (ELISA) measured Elafin concentrations in culture supernatants from tissues treated with LPS and polybacterial combinations of heat-inactivated Mycoplasma hominis (MH), Ureaplasma urealyticum (UU) and Gardnerella vaginalis (GV). Elafin mRNA expression in fetal membranes from women with PPROM was significantly higher compared to women who delivered at term after normal pregnancy (5.09±3.50 vs. 11.71±2.21; P<0.05). In vitro, LPS-stimulated membranes showed a significantly increased Elafin m-RNA expression (P<0.05). However, the protein levels after LPS stimulation was not changed. Similarly, polymicrobial-treated fetal membranes also showed no changes in Elafin protein concentrations compared to untreated controls. Higher Elafin expression in PPROM fetal membranes suggests a host response to an inflammatory pathology. However, lack of Elafin response to LPS and polymicrobial treatment is indicative of the minimal anti-inflammatory impact of this molecule in fetal membranes.

Original languageEnglish (US)
Pages (from-to)237-244
Number of pages8
JournalJournal of Perinatal Medicine
Volume45
Issue number2
DOIs
StatePublished - Feb 1 2017

Fingerprint

Elafin
Extraembryonic Membranes
Anti-Inflammatory Agents
Lipopolysaccharides
Membranes
Rupture
Gardnerella vaginalis
Mycoplasma hominis
Ureaplasma urealyticum
Messenger RNA
Proteins
Reverse Transcription

Keywords

  • Amnion
  • bacteria
  • chorion
  • inflammation
  • pathway
  • PI3
  • polymicrobial infection
  • PPROM
  • preterm birth
  • risk

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Anti-inflammatory Elafin in human fetal membranes. / Stalberg, Cecilia; Noda, Nathalia; Polettini, Jossimara; Jacobsson, Bo; Menon, Ramkumar.

In: Journal of Perinatal Medicine, Vol. 45, No. 2, 01.02.2017, p. 237-244.

Research output: Contribution to journalArticle

Stalberg, C, Noda, N, Polettini, J, Jacobsson, B & Menon, R 2017, 'Anti-inflammatory Elafin in human fetal membranes', Journal of Perinatal Medicine, vol. 45, no. 2, pp. 237-244. https://doi.org/10.1515/jpm-2016-0139
Stalberg, Cecilia ; Noda, Nathalia ; Polettini, Jossimara ; Jacobsson, Bo ; Menon, Ramkumar. / Anti-inflammatory Elafin in human fetal membranes. In: Journal of Perinatal Medicine. 2017 ; Vol. 45, No. 2. pp. 237-244.
@article{bd6fa162cc0c41ee8ba56d138272a461,
title = "Anti-inflammatory Elafin in human fetal membranes",
abstract = "Elafin is a low molecular weight protein with antileukoproteinase, anti-inflammatory, antibacterial and immunomodulating properties. The profile of Elafin in fetal membranes is not well characterized. This study determined the changes in Elafin expression and concentration in human fetal membrane from patients with preterm prelabor rupture of membranes (PPROM) and in vitro in response to intra-amniotic polymicrobial pathogens. Elafin messenger RNA (mRNA) expressions were studied in fetal membranes from PPROM, normal term as well as in normal term not in labor membranes in an organ explant system treated (24 h) with lipopolysaccharide (LPS), using quantitative reverse transcription-polymerase chain reaction (RT-PCR). Enzyme-linked immunosorbent assay (ELISA) measured Elafin concentrations in culture supernatants from tissues treated with LPS and polybacterial combinations of heat-inactivated Mycoplasma hominis (MH), Ureaplasma urealyticum (UU) and Gardnerella vaginalis (GV). Elafin mRNA expression in fetal membranes from women with PPROM was significantly higher compared to women who delivered at term after normal pregnancy (5.09±3.50 vs. 11.71±2.21; P<0.05). In vitro, LPS-stimulated membranes showed a significantly increased Elafin m-RNA expression (P<0.05). However, the protein levels after LPS stimulation was not changed. Similarly, polymicrobial-treated fetal membranes also showed no changes in Elafin protein concentrations compared to untreated controls. Higher Elafin expression in PPROM fetal membranes suggests a host response to an inflammatory pathology. However, lack of Elafin response to LPS and polymicrobial treatment is indicative of the minimal anti-inflammatory impact of this molecule in fetal membranes.",
keywords = "Amnion, bacteria, chorion, inflammation, pathway, PI3, polymicrobial infection, PPROM, preterm birth, risk",
author = "Cecilia Stalberg and Nathalia Noda and Jossimara Polettini and Bo Jacobsson and Ramkumar Menon",
year = "2017",
month = "2",
day = "1",
doi = "10.1515/jpm-2016-0139",
language = "English (US)",
volume = "45",
pages = "237--244",
journal = "Journal of Perinatal Medicine",
issn = "0300-5577",
publisher = "Walter de Gruyter GmbH & Co. KG",
number = "2",

}

TY - JOUR

T1 - Anti-inflammatory Elafin in human fetal membranes

AU - Stalberg, Cecilia

AU - Noda, Nathalia

AU - Polettini, Jossimara

AU - Jacobsson, Bo

AU - Menon, Ramkumar

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Elafin is a low molecular weight protein with antileukoproteinase, anti-inflammatory, antibacterial and immunomodulating properties. The profile of Elafin in fetal membranes is not well characterized. This study determined the changes in Elafin expression and concentration in human fetal membrane from patients with preterm prelabor rupture of membranes (PPROM) and in vitro in response to intra-amniotic polymicrobial pathogens. Elafin messenger RNA (mRNA) expressions were studied in fetal membranes from PPROM, normal term as well as in normal term not in labor membranes in an organ explant system treated (24 h) with lipopolysaccharide (LPS), using quantitative reverse transcription-polymerase chain reaction (RT-PCR). Enzyme-linked immunosorbent assay (ELISA) measured Elafin concentrations in culture supernatants from tissues treated with LPS and polybacterial combinations of heat-inactivated Mycoplasma hominis (MH), Ureaplasma urealyticum (UU) and Gardnerella vaginalis (GV). Elafin mRNA expression in fetal membranes from women with PPROM was significantly higher compared to women who delivered at term after normal pregnancy (5.09±3.50 vs. 11.71±2.21; P<0.05). In vitro, LPS-stimulated membranes showed a significantly increased Elafin m-RNA expression (P<0.05). However, the protein levels after LPS stimulation was not changed. Similarly, polymicrobial-treated fetal membranes also showed no changes in Elafin protein concentrations compared to untreated controls. Higher Elafin expression in PPROM fetal membranes suggests a host response to an inflammatory pathology. However, lack of Elafin response to LPS and polymicrobial treatment is indicative of the minimal anti-inflammatory impact of this molecule in fetal membranes.

AB - Elafin is a low molecular weight protein with antileukoproteinase, anti-inflammatory, antibacterial and immunomodulating properties. The profile of Elafin in fetal membranes is not well characterized. This study determined the changes in Elafin expression and concentration in human fetal membrane from patients with preterm prelabor rupture of membranes (PPROM) and in vitro in response to intra-amniotic polymicrobial pathogens. Elafin messenger RNA (mRNA) expressions were studied in fetal membranes from PPROM, normal term as well as in normal term not in labor membranes in an organ explant system treated (24 h) with lipopolysaccharide (LPS), using quantitative reverse transcription-polymerase chain reaction (RT-PCR). Enzyme-linked immunosorbent assay (ELISA) measured Elafin concentrations in culture supernatants from tissues treated with LPS and polybacterial combinations of heat-inactivated Mycoplasma hominis (MH), Ureaplasma urealyticum (UU) and Gardnerella vaginalis (GV). Elafin mRNA expression in fetal membranes from women with PPROM was significantly higher compared to women who delivered at term after normal pregnancy (5.09±3.50 vs. 11.71±2.21; P<0.05). In vitro, LPS-stimulated membranes showed a significantly increased Elafin m-RNA expression (P<0.05). However, the protein levels after LPS stimulation was not changed. Similarly, polymicrobial-treated fetal membranes also showed no changes in Elafin protein concentrations compared to untreated controls. Higher Elafin expression in PPROM fetal membranes suggests a host response to an inflammatory pathology. However, lack of Elafin response to LPS and polymicrobial treatment is indicative of the minimal anti-inflammatory impact of this molecule in fetal membranes.

KW - Amnion

KW - bacteria

KW - chorion

KW - inflammation

KW - pathway

KW - PI3

KW - polymicrobial infection

KW - PPROM

KW - preterm birth

KW - risk

UR - http://www.scopus.com/inward/record.url?scp=85012879405&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012879405&partnerID=8YFLogxK

U2 - 10.1515/jpm-2016-0139

DO - 10.1515/jpm-2016-0139

M3 - Article

C2 - 27580179

AN - SCOPUS:85012879405

VL - 45

SP - 237

EP - 244

JO - Journal of Perinatal Medicine

JF - Journal of Perinatal Medicine

SN - 0300-5577

IS - 2

ER -